A point-based tool to predict conversion from mild cognitive impairment to probable Alzheimer's disease

[1]  R. Reitan.  Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[2]  P. Rubé,et al.  L’examen Clinique en Psychologie , 1959 .

[3]  E. Kaplan,et al.  The assessment of aphasia and related disorders , 1972 .

[4]  I. T. Draper.  THE ASSESSMENT OF APHASIA AND RELATED DISORDERS , 1973 .

[5]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[6]  W. Kannel,et al.  A general cardiovascular risk profile: the Framingham Study. , 1976, The American journal of cardiology.

[7]  R. Katzman.,et al.  Pathological verification of ischemic score in differentiation of dementias , 1980, Annals of neurology.

[8]  T. Kurosaki,et al.  Measurement of functional activities in older adults in the community. , 1982, Journal of gerontology.

[9]  E. Kaplan,et al.  The Boston naming test , 2001 .

[10]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[11]  R. Nass,et al.  The assessment of aphasia and related disorders By Harold Goodglass and edith kaplan philadelphia, lea & febiger, 1983 illustrated, $27.50 (package) , 1984 .

[12]  K. Davis,et al.  A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.

[13]  J. Yesavage,et al.  Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. , 1986 .

[14]  T. L. Brink,et al.  Clinical Gerontology: A Guide to Assessment and Intervention , 1986 .

[15]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[16]  C. Reynolds,et al.  Wechsler memory scale-revised , 1988 .

[17]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[18]  Robert A. Bornstein,et al.  The Wechsler Memory Scale—Revised , 1990 .

[19]  M. Sliwinski,et al.  Development and validation of a model for estimating premorbid verbal intelligence in the elderly. , 1991, Journal of clinical and experimental neuropsychology.

[20]  R. Mohs,et al.  The Alzheimer's Disease Assessment Scale , 1996, International Psychogeriatrics.

[21]  C. Jack,et al.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment , 1999, Neurology.

[22]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[23]  D. A. Bennett,et al.  Natural history of mild cognitive impairment in older persons , 2002, Neurology.

[24]  Y. Stern,et al.  Functional deficits in patients with mild cognitive impairment: Prediction of AD , 2002, Neurology.

[25]  J. Baron,et al.  Mild cognitive impairment , 2003, Neurology.

[26]  B. Winblad,et al.  Clinical trials in mild cognitive impairment: lessons for the future , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[27]  A. Drzezga,et al.  Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  B. Miller,et al.  Subtype of Mild Cognitive Impairment and Progression to Dementia and Death , 2006, Dementia and Geriatric Cognitive Disorders.

[29]  Karla Lindquist,et al.  Development and validation of a prognostic index for 4-year mortality in older adults. , 2006, JAMA.

[30]  C. Jack,et al.  3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. , 2007, Brain : a journal of neurology.

[31]  H. Engler,et al.  PET imaging of amyloid deposition in patients with mild cognitive impairment , 2008, Neurobiology of Aging.

[32]  R. Petersen,et al.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.

[33]  C. Jack,et al.  Mild cognitive impairment: ten years later. , 2009, Archives of neurology.

[34]  K Yaffe,et al.  Predicting risk of dementia in older adults , 2009, Neurology.

[35]  Li Shen,et al.  Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort , 2009, Current Alzheimer research.

[36]  C. Jack,et al.  MRI and CSF biomarkers in normal, MCI, and AD subjects , 2009, Neurology.

[37]  Cindee M. Madison,et al.  Comparing predictors of conversion and decline in mild cognitive impairment , 2010, Neurology.

[38]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[39]  Jesse S. Jin,et al.  Identification of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Predictors , 2011, PloS one.

[40]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[41]  Ronald C Petersen,et al.  Outcomes of mild cognitive impairment by definition: a population study. , 2011, Archives of neurology.

[42]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[43]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[44]  Klaus P. Ebmeier,et al.  A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease , 2011, Neurobiology of Aging.

[45]  C. Rowe,et al.  Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease , 2011, Annals of neurology.

[46]  J. Trojanowski,et al.  Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification , 2011, Neurobiology of Aging.

[47]  Nick C Fox,et al.  The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .

[48]  T. Goldberg,et al.  Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative. , 2011, Archives of general psychiatry.

[49]  C. Jack,et al.  Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance , 2012, Neurobiology of Aging.

[50]  Mark E. Schmidt,et al.  The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception , 2012, Alzheimer's & Dementia.

[51]  Jieping Ye,et al.  Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data , 2012, BMC Neurology.

[52]  Y. Stern,et al.  A Two-Study Comparison of Clinical and MRI Markers of Transition from Mild Cognitive Impairment to Alzheimer's Disease , 2012, Alzheimer's & Dementia.

[53]  P. Sachdev,et al.  Mild cognitive impairment in a community sample: The Sydney Memory and Ageing Study , 2013, Alzheimer's & Dementia.

[54]  W. J. Boscardin,et al.  Estimating Harrell's Optimism on Predictive Indices Using Bootstrap Samples , 2013 .

[55]  P. Trzepacz,et al.  Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia , 2013, Neurobiology of Aging.